CAJ | 학술논문

硬化治疗以其微创、安全、有效等优点在良性卵巢囊肿中广泛应用，硬化剂在硬化治疗中起到关键性作用。无水乙醇作为经典的硬化剂在临床使用中仍存在诸多问题。乙氧硬化醇作为国内新研发并得到药物使用批准文号的硬化剂逐步得到推广和使用，有望成为无水乙醇的替代物，具有良好的应用前景和发展价值。该文就硬化剂在良性卵巢囊肿中的应用进展进行综述。
경화치료이기미창、안전、유효등우점재량성란소낭종중엄범응용，경화제재경화치료중기도관건성작용。무수을순작위경전적경화제재림상사용중잉존재제다문제。을양경화순작위국내신연발병득도약물사용비준문호적경화제축보득도추엄화사용，유망성위무수을순적체대물，구유량호적응용전경화발전개치。해문취경화제재량성란소낭종중적응용진전진행종술。
Sclerotherapy have been used widely in the treatment of benign ovarian cysts with its advantages of minimal invasiveness,safety, effectiveness,hardening agent play a crucial role in the sclerotherapy .As classical hard-ening agent ,anhydrous ethanol had many problems in the clinical practice .Lauromacrogol is a new medicine , which having obtained drug approval numbers in China ,it may become an optimal substitute to anhydrous ethanol in sclero-therapy.It has wide application value and development prospect .In this article, the application of hardening agent in benign ovarian cysts was reviewed .